Loading…

Biologically active secondary metabolites and biotechnological applications of species of the family Chaetomiaceae (Sordariales): an updated review from 2016 to 2021

Fungi are eukaryotic organisms that have the ability to synthesize an enormous number of metabolites with a vast diversity of chemical structures and bioactivities. Chaetomiaceae species are a wealthy source of enzymes with diverse biotechnological and industrial applications such as PMO (polysaccha...

Full description

Saved in:
Bibliographic Details
Published in:Mycological progress 2021-05, Vol.20 (5), p.595-639
Main Authors: Ibrahim, Sabrin R. M., Mohamed, Shaimaa G. A., Sindi, Ikhlas A., Mohamed, Gamal A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c319t-3bba154176c7c9bd0764d1c8f43ca84099d42f2f7c64709e8ab420812bf1a4653
cites cdi_FETCH-LOGICAL-c319t-3bba154176c7c9bd0764d1c8f43ca84099d42f2f7c64709e8ab420812bf1a4653
container_end_page 639
container_issue 5
container_start_page 595
container_title Mycological progress
container_volume 20
creator Ibrahim, Sabrin R. M.
Mohamed, Shaimaa G. A.
Sindi, Ikhlas A.
Mohamed, Gamal A.
description Fungi are eukaryotic organisms that have the ability to synthesize an enormous number of metabolites with a vast diversity of chemical structures and bioactivities. Chaetomiaceae species are a wealthy source of enzymes with diverse biotechnological and industrial applications such as PMO (polysaccharide monooxygenase), L-methioninase, β-1,3-glucanase, laccase, dextranase, lipolytic, pectinolytic, amylolytic, chitinolytic, and proteolytic enzymes. Different classes of secondary metabolites have been reported from this family are derived from various biosynthetic pathways such as alkaloids, polyketides, peptides, terpenes, and polyketide-amino acid hybrid secondary metabolites. These metabolites have attracted research interest due to their fascinating structural frameworks and bioactivities. Therefore, these compounds can be taken into account as candidates for the development of effective and novel lead compounds for medicine, as well as for plant protection. The current review represents the relevant information for Chaetomiaceae species, in particular, its new and first reported secondary metabolites and their pharmacological activities, as well as the biotechnological applications published from 2016 until the beginning of 2021.
doi_str_mv 10.1007/s11557-021-01704-w
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2522682042</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2522682042</sourcerecordid><originalsourceid>FETCH-LOGICAL-c319t-3bba154176c7c9bd0764d1c8f43ca84099d42f2f7c64709e8ab420812bf1a4653</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhSMEEqXwBzhZ6qUcUjyOYye90RVQpEocoBI3a-KMu66SOLW9XfUH9X9iulTcOM07vPfNaF5VvQd-BpzrjwmgbXXNBdQcNJf1_kV1BJ2Cuutb8bJoBbqWoH69rt6kdMu5lJI3R9XjhQ9TuPEWp-mBoc3-nlgiG5YR4wObKeMQJp8pMVxGNviQyW6X5wzDdZ2KyD4siQXH0krW05PMW2IOZ1-4my1SDrNHS0js9EeIhe5xovThvHDZbh0x08gi3XvaMxfDzAQHxXIoU8Db6pXDKdG7v_O4uv7y-efmsr76_vXb5tNVbRvoc90MA0IrQSurbT-MXCs5gu2cbCx2kvf9KIUTTlslNe-pw0EK3oEYHKBUbXNcnRy4awx3O0rZ3IZdXMpKI1ohVCe4FMUlDi4bQ0qRnFmjn8u7DHDzpw5zqMOUy81THWZfQs0hlIp5uaH4D_2f1G_IBo-d</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2522682042</pqid></control><display><type>article</type><title>Biologically active secondary metabolites and biotechnological applications of species of the family Chaetomiaceae (Sordariales): an updated review from 2016 to 2021</title><source>Springer Link</source><creator>Ibrahim, Sabrin R. M. ; Mohamed, Shaimaa G. A. ; Sindi, Ikhlas A. ; Mohamed, Gamal A.</creator><creatorcontrib>Ibrahim, Sabrin R. M. ; Mohamed, Shaimaa G. A. ; Sindi, Ikhlas A. ; Mohamed, Gamal A.</creatorcontrib><description>Fungi are eukaryotic organisms that have the ability to synthesize an enormous number of metabolites with a vast diversity of chemical structures and bioactivities. Chaetomiaceae species are a wealthy source of enzymes with diverse biotechnological and industrial applications such as PMO (polysaccharide monooxygenase), L-methioninase, β-1,3-glucanase, laccase, dextranase, lipolytic, pectinolytic, amylolytic, chitinolytic, and proteolytic enzymes. Different classes of secondary metabolites have been reported from this family are derived from various biosynthetic pathways such as alkaloids, polyketides, peptides, terpenes, and polyketide-amino acid hybrid secondary metabolites. These metabolites have attracted research interest due to their fascinating structural frameworks and bioactivities. Therefore, these compounds can be taken into account as candidates for the development of effective and novel lead compounds for medicine, as well as for plant protection. The current review represents the relevant information for Chaetomiaceae species, in particular, its new and first reported secondary metabolites and their pharmacological activities, as well as the biotechnological applications published from 2016 until the beginning of 2021.</description><identifier>ISSN: 1617-416X</identifier><identifier>EISSN: 1861-8952</identifier><identifier>DOI: 10.1007/s11557-021-01704-w</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Amino acids ; Biological activity ; Biomedical and Life Sciences ; Biotechnology ; Chaetomiaceae ; Dextranase ; Ecology ; Enzymes ; Industrial applications ; Laccase ; Lead compounds ; Life Sciences ; Medicinal plants ; Metabolites ; Microbiology ; Monooxygenase ; Peptides ; Plant protection ; Plant Sciences ; Polyketides ; Polysaccharides ; Proteolysis ; Proteolytic enzymes ; Review Article ; Secondary metabolites ; Species ; Terpenes</subject><ispartof>Mycological progress, 2021-05, Vol.20 (5), p.595-639</ispartof><rights>German Mycological Society and Springer-Verlag GmbH Germany, part of Springer Nature 2021</rights><rights>German Mycological Society and Springer-Verlag GmbH Germany, part of Springer Nature 2021.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c319t-3bba154176c7c9bd0764d1c8f43ca84099d42f2f7c64709e8ab420812bf1a4653</citedby><cites>FETCH-LOGICAL-c319t-3bba154176c7c9bd0764d1c8f43ca84099d42f2f7c64709e8ab420812bf1a4653</cites><orcidid>0000-0002-6858-7560</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Ibrahim, Sabrin R. M.</creatorcontrib><creatorcontrib>Mohamed, Shaimaa G. A.</creatorcontrib><creatorcontrib>Sindi, Ikhlas A.</creatorcontrib><creatorcontrib>Mohamed, Gamal A.</creatorcontrib><title>Biologically active secondary metabolites and biotechnological applications of species of the family Chaetomiaceae (Sordariales): an updated review from 2016 to 2021</title><title>Mycological progress</title><addtitle>Mycol Progress</addtitle><description>Fungi are eukaryotic organisms that have the ability to synthesize an enormous number of metabolites with a vast diversity of chemical structures and bioactivities. Chaetomiaceae species are a wealthy source of enzymes with diverse biotechnological and industrial applications such as PMO (polysaccharide monooxygenase), L-methioninase, β-1,3-glucanase, laccase, dextranase, lipolytic, pectinolytic, amylolytic, chitinolytic, and proteolytic enzymes. Different classes of secondary metabolites have been reported from this family are derived from various biosynthetic pathways such as alkaloids, polyketides, peptides, terpenes, and polyketide-amino acid hybrid secondary metabolites. These metabolites have attracted research interest due to their fascinating structural frameworks and bioactivities. Therefore, these compounds can be taken into account as candidates for the development of effective and novel lead compounds for medicine, as well as for plant protection. The current review represents the relevant information for Chaetomiaceae species, in particular, its new and first reported secondary metabolites and their pharmacological activities, as well as the biotechnological applications published from 2016 until the beginning of 2021.</description><subject>Amino acids</subject><subject>Biological activity</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnology</subject><subject>Chaetomiaceae</subject><subject>Dextranase</subject><subject>Ecology</subject><subject>Enzymes</subject><subject>Industrial applications</subject><subject>Laccase</subject><subject>Lead compounds</subject><subject>Life Sciences</subject><subject>Medicinal plants</subject><subject>Metabolites</subject><subject>Microbiology</subject><subject>Monooxygenase</subject><subject>Peptides</subject><subject>Plant protection</subject><subject>Plant Sciences</subject><subject>Polyketides</subject><subject>Polysaccharides</subject><subject>Proteolysis</subject><subject>Proteolytic enzymes</subject><subject>Review Article</subject><subject>Secondary metabolites</subject><subject>Species</subject><subject>Terpenes</subject><issn>1617-416X</issn><issn>1861-8952</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kUFv1DAQhSMEEqXwBzhZ6qUcUjyOYye90RVQpEocoBI3a-KMu66SOLW9XfUH9X9iulTcOM07vPfNaF5VvQd-BpzrjwmgbXXNBdQcNJf1_kV1BJ2Cuutb8bJoBbqWoH69rt6kdMu5lJI3R9XjhQ9TuPEWp-mBoc3-nlgiG5YR4wObKeMQJp8pMVxGNviQyW6X5wzDdZ2KyD4siQXH0krW05PMW2IOZ1-4my1SDrNHS0js9EeIhe5xovThvHDZbh0x08gi3XvaMxfDzAQHxXIoU8Db6pXDKdG7v_O4uv7y-efmsr76_vXb5tNVbRvoc90MA0IrQSurbT-MXCs5gu2cbCx2kvf9KIUTTlslNe-pw0EK3oEYHKBUbXNcnRy4awx3O0rZ3IZdXMpKI1ohVCe4FMUlDi4bQ0qRnFmjn8u7DHDzpw5zqMOUy81THWZfQs0hlIp5uaH4D_2f1G_IBo-d</recordid><startdate>20210501</startdate><enddate>20210501</enddate><creator>Ibrahim, Sabrin R. M.</creator><creator>Mohamed, Shaimaa G. A.</creator><creator>Sindi, Ikhlas A.</creator><creator>Mohamed, Gamal A.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>M7N</scope><orcidid>https://orcid.org/0000-0002-6858-7560</orcidid></search><sort><creationdate>20210501</creationdate><title>Biologically active secondary metabolites and biotechnological applications of species of the family Chaetomiaceae (Sordariales): an updated review from 2016 to 2021</title><author>Ibrahim, Sabrin R. M. ; Mohamed, Shaimaa G. A. ; Sindi, Ikhlas A. ; Mohamed, Gamal A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c319t-3bba154176c7c9bd0764d1c8f43ca84099d42f2f7c64709e8ab420812bf1a4653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Amino acids</topic><topic>Biological activity</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnology</topic><topic>Chaetomiaceae</topic><topic>Dextranase</topic><topic>Ecology</topic><topic>Enzymes</topic><topic>Industrial applications</topic><topic>Laccase</topic><topic>Lead compounds</topic><topic>Life Sciences</topic><topic>Medicinal plants</topic><topic>Metabolites</topic><topic>Microbiology</topic><topic>Monooxygenase</topic><topic>Peptides</topic><topic>Plant protection</topic><topic>Plant Sciences</topic><topic>Polyketides</topic><topic>Polysaccharides</topic><topic>Proteolysis</topic><topic>Proteolytic enzymes</topic><topic>Review Article</topic><topic>Secondary metabolites</topic><topic>Species</topic><topic>Terpenes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ibrahim, Sabrin R. M.</creatorcontrib><creatorcontrib>Mohamed, Shaimaa G. A.</creatorcontrib><creatorcontrib>Sindi, Ikhlas A.</creatorcontrib><creatorcontrib>Mohamed, Gamal A.</creatorcontrib><collection>CrossRef</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><jtitle>Mycological progress</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ibrahim, Sabrin R. M.</au><au>Mohamed, Shaimaa G. A.</au><au>Sindi, Ikhlas A.</au><au>Mohamed, Gamal A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biologically active secondary metabolites and biotechnological applications of species of the family Chaetomiaceae (Sordariales): an updated review from 2016 to 2021</atitle><jtitle>Mycological progress</jtitle><stitle>Mycol Progress</stitle><date>2021-05-01</date><risdate>2021</risdate><volume>20</volume><issue>5</issue><spage>595</spage><epage>639</epage><pages>595-639</pages><issn>1617-416X</issn><eissn>1861-8952</eissn><abstract>Fungi are eukaryotic organisms that have the ability to synthesize an enormous number of metabolites with a vast diversity of chemical structures and bioactivities. Chaetomiaceae species are a wealthy source of enzymes with diverse biotechnological and industrial applications such as PMO (polysaccharide monooxygenase), L-methioninase, β-1,3-glucanase, laccase, dextranase, lipolytic, pectinolytic, amylolytic, chitinolytic, and proteolytic enzymes. Different classes of secondary metabolites have been reported from this family are derived from various biosynthetic pathways such as alkaloids, polyketides, peptides, terpenes, and polyketide-amino acid hybrid secondary metabolites. These metabolites have attracted research interest due to their fascinating structural frameworks and bioactivities. Therefore, these compounds can be taken into account as candidates for the development of effective and novel lead compounds for medicine, as well as for plant protection. The current review represents the relevant information for Chaetomiaceae species, in particular, its new and first reported secondary metabolites and their pharmacological activities, as well as the biotechnological applications published from 2016 until the beginning of 2021.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s11557-021-01704-w</doi><tpages>45</tpages><orcidid>https://orcid.org/0000-0002-6858-7560</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1617-416X
ispartof Mycological progress, 2021-05, Vol.20 (5), p.595-639
issn 1617-416X
1861-8952
language eng
recordid cdi_proquest_journals_2522682042
source Springer Link
subjects Amino acids
Biological activity
Biomedical and Life Sciences
Biotechnology
Chaetomiaceae
Dextranase
Ecology
Enzymes
Industrial applications
Laccase
Lead compounds
Life Sciences
Medicinal plants
Metabolites
Microbiology
Monooxygenase
Peptides
Plant protection
Plant Sciences
Polyketides
Polysaccharides
Proteolysis
Proteolytic enzymes
Review Article
Secondary metabolites
Species
Terpenes
title Biologically active secondary metabolites and biotechnological applications of species of the family Chaetomiaceae (Sordariales): an updated review from 2016 to 2021
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T05%3A47%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biologically%20active%20secondary%20metabolites%20and%20biotechnological%20applications%20of%20species%20of%20the%20family%20Chaetomiaceae%20(Sordariales):%20an%20updated%20review%20from%202016%20to%202021&rft.jtitle=Mycological%20progress&rft.au=Ibrahim,%20Sabrin%20R.%20M.&rft.date=2021-05-01&rft.volume=20&rft.issue=5&rft.spage=595&rft.epage=639&rft.pages=595-639&rft.issn=1617-416X&rft.eissn=1861-8952&rft_id=info:doi/10.1007/s11557-021-01704-w&rft_dat=%3Cproquest_cross%3E2522682042%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c319t-3bba154176c7c9bd0764d1c8f43ca84099d42f2f7c64709e8ab420812bf1a4653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2522682042&rft_id=info:pmid/&rfr_iscdi=true